Activation of b-catenin, the principal mediator of canonical Wnt signaling, is a common pathologic finding in a wide variety of chronic kidney diseases (CKD). While b-catenin is induced predominantly in renal tubular epithelium in CKD, surprisingly, depletion of tubular b-catenin had little effect on the severity of renal fibrosis. Interestingly, less apoptosis was detected in interstitial fibroblasts in knockout mice, which was accompanied by a decreased expression of Bax and Fas ligand (FasL). Tubule-specific knockout of b-catenin diminished renal induction of matrix metalloproteinase (MMP-7), which induced FasL expression in interstitial fibroblasts and potentiated fibroblast apoptosis in vitro. These results demonstrate that loss of tubular b-catenin resulted in enhanced interstitial fibroblast survival due to decreased MMP-7 expression. Our studies uncover a novel role of the tubular b-catenin/MMP-7 axis in controlling the fate of interstitial fibroblasts via epithelial-mesenchymal communication.
R
enal fibrosis is the common final outcome of a wide variety of progressive chronic kidney diseases (CKD). After initial insults, tissue fibrogenesis occurs as a dynamic process consisting of four overlapping phases: priming, activation, execution and progression, in which fibroblast activation is a key step 1 . In normal adult kidneys, fibroblasts are quiescent in nature and scarce in numbers, and are situated in the interstitial space between the capillaries and tubular epithelium. Upon activation by profibrotic cytokines and/or mechanical stress in vivo, fibroblasts acquire a myofibroblast phenotype by expressing a-smooth muscle actin (a-SMA) and produce a large amount of extracellular matrix (ECM) components [1] [2] [3] . Studies indicate that activated fibroblasts in diseased kidneys could derive from different sources via diverse mechanisms, including activation of interstitial fibroblasts and pericytes, phenotypic conversion of tubular epithelia and endothelial cells, and recruitment of circulating fibrocytes [4] [5] [6] [7] [8] [9] . Conceivably, the size of the fibroblast population, defined by the dynamic balance of fibroblast generation and depletion, is a major determinant of renal fibrotic lesions and kidney dysfunction. Despite significant advances in our understanding of the origins and activation of matrix-producing fibroblasts in recent years, little is known on the regulation of fibroblast fate in diseased kidneys. Furthermore, it remains completely elusive as to the mediators and mechanisms controlling fibroblast apoptosis and depletion in vivo.
Wnt/b-catenin is a highly conserved signaling cascade associated with a myriad of biologic actions [10] [11] [12] . Upon binding to their plasma membrane receptors, Wnts trigger a series of signaling events that result in stabilization of b-catenin, which then enters the nucleus to control the expression of its target genes by interacting with the T cell factor (TCF)/lymphoid enhancer factor (LEF) family of transcription factors. One downstream target gene of Wnt/b-catenin signaling is matrix metalloproteinase-7 (MMP-7), a secreted, zinc-and calcium-dependent endopeptidase that degrades a broad range of ECM substrates 13, 14 . MMP-7 is also known to cleave non-ECM proteins such as E-cadherin and Fas Ligand (FasL), and therefore plays important roles in the regulation of diverse biologic processes such as epithelial-mesenchymal transition (EMT) and cell apoptosis [15] [16] [17] . We have previously shown that urinary MMP-7 is a surrogate marker that predicts renal Wnt/b-catenin activity in diseased kidneys 18 . Activation of Wnt/b-catenin signaling is a common pathologic finding in a wide variety of CKDs [19] [20] [21] [22] . Of interest, b-catenin is predominantly up-regulated in renal tubular epithelium of the fibrotic kidneys, suggesting that tubular cells are the major targets of canonical Wnt signaling. Earlier studies indicate that pharmacologic inhibition of Wnt/b-catenin signaling by different approaches is renoprotective, leading to amelioration of renal fibrosis several fibrosis-related genes such as Snail1, plasminogen activator inhibitor 1 (PAI-1), MMP-7 and fibronectin 18, 25, 26 . These results suggest that activation of tubular b-catenin probably plays a critical role in the pathogenesis and progression of renal fibrosis. However, the exact role of tubular b-catenin in renal fibrogenesis in vivo remains poorly understood.
In this study, by using conditional knockout mice in which bcatenin is genetically ablated in a tubule-specific fashion, we investigated the role of tubular b-catenin in a mouse model of renal fibrosis induced by unilateral ureteral obstruction (UUO). Surprisingly, we found that loss of tubular b-catenin did not result in any difference in the severity and magnitude of renal fibrosis after UUO. However, we show that tubular b-catenin signaling controls interstitial fibroblast apoptosis through epithelial-mesenchymal communication (EMC) mediated by MMP-7 and FasL. As such, tubular b-catenin plays a pivotal role in fibroblast homeostasis.
Results
Tubule-specific ablation of b-catenin does not affect renal fibrosis. We first sought to confirm that endogenous b-catenin is depleted in a tubule-specific fashion in conditional b-catenin knockout mice (Ksp-b-cat-/-). As shown in Figure 1a , b-catenin was induced predominantly in renal tubular epithelium at 7 days after unilateral ureteral obstruction (UUO) in control mice, as previously reported 19 . However, b-catenin induction was largely abolished in the tubular epithelium of Ksp-b-cat-/-mice ( Figure 1, a and b) . Similar results were obtained by Western blot analyses of whole kidney lysates ( Figure 1, c and d) . These data confirm an efficient depletion of endogenous b-catenin in a tubule-specific fashion.
We next examined the effect of tubule-specific depletion of bcatenin on renal interstitial fibrosis induced by obstructive injury. As shown in Figure 1 , e through g, loss of tubular b-catenin did not have any significant impact on the severity of renal fibrosis after UUO. Virtually identical levels of collagen deposition and renal fibrotic lesions were observed in the obstructed kidneys in Ksp-b-cat-/-and control mice, as illustrated by Masson's Trichrome staining. Similar results were obtained by immunofluorescence staining for fibronectin and collagen III (Figure 1, e and g ).
We further examined the expression of various fibrosis-related genes by quantitative, real-time RT-PCR. As shown in Figure 2 , a through d, tubule-specific ablation of b-catenin had no effect on renal mRNA expression of numerous fibrosis-related genes such as fibronectin, collagen III, transforming growth factor-b1 (TGF-b1) and connective tissue growth factor (CTGF). Similarly, there was no Depletion of tubular b-catenin reduces epithelial-mesenchymal transition in vivo. Given that b-catenin signaling is instrumental in mediating epithelial-mesenchymal transition (EMT) in vitro 25 , we next investigated the effect of tubule-specific loss of b-catenin on this process after obstructive injury. E-cadherin, a tubular epithelial adherens receptor, was largely diminished in the tubular epithelium of control mice at 7 days after UUO 27 . However, as shown in Figure 3 , depletion of b-catenin in Ksp-b-cat-/-mice resulted in an upregulation of E-cadherin expression in renal tubules at 7 days after UUO ( Figure 3 , a through c). As loss of E-cadherin is an early and key step in EMT 28 , these data suggest that tubule-specific loss of bcatenin preserves tubular epithelial integrity and prevents EMT after obstructive injury in vivo.
EMT is often accompanied by an E-cadherin/N-cadherin switch 29, 30 . We therefore examined N-cadherin expression by immunofluorescence staining. As shown in Figure 3d , concomitant with an increased E-cadherin, N-cadherin expression was reduced in the obstructed kidneys of Ksp-b-cat-/-mice at 7 days after UUO, compared with the controls. We further investigated the expression and localization of vimentin, an intermediate cytoskeleton protein and a specific marker for mesenchymal cells 1 , in the obstructed kidneys at different time points after UUO. As shown in Figure 3 , e and f, Western blot analyses revealed a substantial reduction of vimentin in Ksp-b-cat-/-kidneys at 3 and 7 days after UUO, respectively, compared to controls. Immunohistochemical staining showed a significant number of tubular cells stained positively for vimentin in the obstructed kidneys of control mice (Figure 3g , yellow arrows). However, tubular expression of vimentin was rare in the Ksp-bcat-/-kidneys at different time points after UUO. Quantitative data on vimentin-positive tubular cells are presented in Figure 3 , h and i. These results illustrate that loss of b-catenin in a tubule-specific fashion reduces EMT in vivo.
Depletion of b-catenin in renal tubules does not alter the size of the fibroblast population. Despite a reduced tubular EMT (Figure 3 ), we found that depletion of b-catenin in renal tubules did not significantly affect the pool size of renal myofibroblasts, a unique cell population that is believed to be the principal matrixproducing cells in fibrotic tissues 1, 7, 8 . As shown in Figure 4a , qRT-PCR demonstrated no significant differences in the expression of a-SMA, the molecular signature of myofibroblasts, between Ksp-bcat-/-and control kidneys at 7 days after UUO. Similarly, Western blot analyses and immunohistochemical staining also revealed comparable a-SMA protein expression in the obstructed kidneys at 7 days after UUO ( Figure 4 , b through d), suggesting a similar size of the myofibroblast population. Consistently, no difference in a-SMA expression was found in the obstructed kidneys between control and Ksp-b-cat-/-mice at 3 days after UUO ( Figure 4 , e and f). These data suggest that despite a reduced contribution by EMT, the pool size of renal myofibroblast remains unchanged in the Ksp-b-cat-/-kidneys after UUO.
Tubular depletion of b-catenin promotes interstitial fibroblast survival. The size of the myofibroblast population is conceivably determined by the balance of the generation and depletion of these cells. Therefore, we examined cell apoptosis. Earlier studies indicate that b-catenin is an important player in tubular cell survival after acute kidney injury 31, 32 . Surprisingly, we found that apoptosis was substantially reduced in Ksp-b-cat-/-mice after UUO, compared to the controls. As shown in Figure 5 , a through d, Western blot analyses of whole kidney lysates showed an overall reduction of proapoptotic Bax and FasL protein expression in the obstructed kidneys in Ksp-b-cat-/-mice. Consistently, TUNEL staining revealed significant numbers of apoptotic cells in the obstructed kidneys of control mice at 7 days after UUO, which were largely localized to the interstitial compartment ( Figure 5e , blue arrows in boxed area). In Ksp-b-cat-/-mice, apoptotic cells in renal interstitium were decreased, compared to control mice, while tubular cell apoptosis was unchanged (Figure 5e , yellow arrows in the boxed area). To further characterize the identity of apoptotic cells, kidney sections were co-stained with TUNEL and anti-vimentin antibody. As shown in Figure 5g , fewer fibroblasts underwent apoptosis in Ksp-b-cat-/- Tubular depletion of b-catenin abolishes renal MMP-7 induction. The observation that loss of tubular b-catenin promotes interstitial fibroblast survival clearly suggests an active epithelial-mesenchymal communication (EMC) in the injured kidneys. We hypothesized that such an EMC may be mediated by secreted factors that are regulated by b-catenin. To test this hypothesis, we examined the expression of MMP-7, a direct transcriptional target of b-catenin that is implicated in regulating cell survival. As shown in Figure 6 , qRT-PCR analyses revealed a marked reduction of MMP-7 mRNA expression in the obstructed kidneys of Ksp-b-cat-/-mice at 7 days after UUO, compared to control mice. Immunohistochemical staining demonstrated that MMP-7 protein was predominantly induced in the tubular epithelium of the obstructed kidneys after UUO. However, tubule-specific depletion of b-catenin resulted in a dramatic loss of MMP-7 protein expression in Ksp-b-cat-/-mice, consistent with the notion that MMP-7 is a direct target of b-catenin.
MMP-7 induces FasL expression and potentiates fibroblast apoptosis. To investigate the role of tubule-derived MMP-7 in controlling interstitial fibroblast apoptosis, we examined the potential of recombinant MMP-7 in regulating key cell survival/apoptosis pathways in vitro. As shown in Figure 7 , A and B, MMP-7 induced FasL expression in normal rat kidney interstitial fibroblasts (NRK-49F) in a time-and dose-dependent manner. As FasL is a key player in the extrinsic, receptor-mediated apoptosis pathway 33, 34 , these results suggest that tubule-derived MMP-7 can directly regulate fibroblast survival. Notably, renal FasL expression was markedly induced in the obstructed kidneys after UUO in control mice ( Figure 5, c and d) . However, tubule-specific depletion of bcatenin abolished FasL induction, presumably due to repression of MMP-7 expression in Ksp-b-cat-/-kidneys. To ascertain the direct involvement of tubule-derived MMP-7 in controlling the fate of interstitial fibroblasts, we examined the ability of exogenous MMP-7 to induce fibroblast apoptosis in vitro. As shown in Figure 7 , a through c, incubation of NRK-49F cells with MMP-7 alone did not significantly influence cell survival/apoptosis, as Bax expression and apoptosis detected by TUNEL staining were not significantly changed. However, MMP-7 markedly potentiated staurosporine-triggered fibroblast apoptotic cell death. In the presence of staurosporine, MMP-7 promoted renal interstitial fibroblast apoptosis in a time-and dose-dependent manner, as illustrated by TUNEL staining (Figure 7, d through g ). Consistently, MMP-7 also induced pro-apoptotic Bax protein expression in NRK-49F cells in the presence of staurosporine ( Figure 7, h and i) . These results demonstrate that tubule-derived MMP-7 mediates an active epithelialmesenchymal communication, thereby controlling interstitial fibroblast fate in fibrotic kidneys.
Discussion
Given that b-catenin is predominantly induced in renal tubular epithelium in fibrotic kidneys and that pharmacological inhibition of bcatenin signaling is renal protective 19, 25 , we originally speculated that genetic ablation of tubular b-catenin protects kidneys against development of fibrotic lesions. To our surprise, knockout of b-catenin in a tubule-specific fashion did not alter the severity of renal fibrosis after obstructive injury. Furthermore, the size of the myofibroblast population, reflected by renal a-SMA expression, was similar between control and Ksp-b-cat-/-mice at different time points after UUO. As illustrated in Figure 8 , in control mice, tubular activation of b-catenin after injury leads to EMT (solid arrow) and upregulates tubular MMP-7 expression and secretion 18, 25, 35 . As a result, secreted MMP-7 induces FasL expression in interstitial fibroblasts and potentiates their apoptosis. However, in Ksp-b-cat-/-mice, despite presumably less fibroblasts being generated from tubular EMT in the absence of b-catenin (empty arrow), interstitial fibroblasts have a prolonged life-span due to reduced apoptosis. Therefore, the net size of the interstitial myofibroblast pool in control and Ksp-b-cat-/-kidneys is actually unchanged, which results in similar fibrotic lesions. These data demonstrate that tubular b-catenin controls interstitial fibroblast fate via MMP-7-mediated epithelialmesenchymal communication.
Activated fibroblasts, characterized by a-SMA and type I collagen expression, are the principal matrix-producing cells that play a central role in the scar formation of kidney parenchyma 1, 3 . While the origins and activation processes of interstitial fibroblasts have been extensively studied in recent years [4] [5] [6] 36, 37 , little is known about the fate of interstitial fibroblasts after activation in diseased kidneys. In this regard, the present study represents the first report on the regulation of interstitial fibroblast fate in vivo, and provides significant insights into the mediators and mechanisms underlying fibroblast apoptosis. The fact that the survival or death of interstitial fibroblasts is dictated by the b-catenin signaling in renal tubules demonstrates an active crosstalk between tubular epithelium and interstitial fibroblasts during renal fibrogenesis, consistent with a recent report that tubulederived sonic hedgehog (shh) targets interstitial fibroblasts for their activation 38 . It should be pointed out that despite a reduced rate of apoptosis, the volume of fibroblast population in Ksp-b-cat-/-kidneys after UUO is similar to that in controls (Figure 8 ). This suggests a possible deficiency in fibroblast generation in the absence of tubular b-catenin in Ksp-b-cat-/-mice, as the size of the fibroblast pool is determined by the balance between its generation and its depletion via apoptosis. Although activated fibroblasts could originate from different sources such as quiescent fibroblasts, pericytes, or tubular epithelial cells via distinct pathways 1, 6, 7 , it is conceivable that a diminished tubular EMT may account for less efficiency in fibroblast generation in Ksp-b-cat-/-kidneys. This notion is supported by the observation that b-catenin activation induces tubular EMT in vitro 25 . Consistently, tubular epithelial cell E-cadherin is largely preserved and de novo expression of vimentin in renal tubules is prevented in Ksp-b-cat-/-kidneys after obstructive injury (Figure 3 ). Taken together, these results are in harmony with the notion that loss of b-catenin reduces tubular EMT in vivo.
The present study has identified secreted MMP-7 as the intercellular agent that mediates tubular epithelial-interstitial fibroblast communication. This notion is supported by several lines of evidence. First, MMP-7 is a direct transcriptional target of canonical Wnt/b-catenin signaling 18, 39 , and is induced specifically in renal tubular epithelium (Figure 6c) . Second, ablation of tubular b-catenin abolishes MMP-7 induction in renal tubules after UUO in vivo (Figure 6d) . Third, MMP-7 potentiates interstitial fibroblast apoptosis in vitro (Figure 7) . Finally, loss of tubular b-catenin/MMP-7 results in decreased fibroblast apoptosis in vivo ( Figure 5 ). Collectively, these findings strongly implicate MMP-7 in regulating fibroblast fate via epithelial-mesenchymal communication, although we cannot exclude other possibilities.
It should be noted that MMP-7 could also influence renal fibrosis by controlling EMT via a multitude of mechanisms 13, 18 . First, MMP-7 induces proteolytic degradation of E-cadherin 15, 18 , an epithelial cell adhesion receptor that is essential for the maintenance of tubular epithelial integrity. As destruction of E-cadherin is the initial step during EMT 28 , MMP-7-mediated E-cadherin ectodomain shedding undoubtedly contributes to the tubular epithelial injury and promotes EMT in diseased kidneys. Furthermore, as MMP-7 degrades collagen IV and laminin, the major components of tubular basement membrane (TBM), it is conceivable that increased MMP-7 would aggravate TBM damage, which facilitates tubular EMT in the fibrotic kidneys 13 . Consistently, tubule-specific knockout of b-catenin leads to suppression of MMP-7 expression and preservation of E-cadherin, as well as inhibition of tubular vimentin expression. This provides a rational explanation for the reduced EMT observed in Ksp-b-cat-/-kidneys after UUO.
In addition to regulating EMT, we report here a novel function for MMP-7 in controlling fibroblast survival and apoptosis in diseased kidneys. Apoptosis is a programmed cell death regulated by either intrinsic, mitochondria-dependent or extrinsic, receptor-mediated mechanisms 33, 40, 41 . Of the extrinsic apoptosis pathways, the engagement of Fas and FasL on adjacent cells is an important pathway in controlling cell death, and earlier studies demonstrate that MMP-7 protects tumor cells against apoptosis by proteolytically cleaving FasL 16, 42 . However, we found that MMP-7 induces FasL expression in renal interstitial fibroblasts (Figure 7) . Consistently, depletion of tubular b-catenin in Ksp-b-cat-/-mice leads to MMP-7 suppression and abolishes renal FasL induction ( Figure 5 ), which results in the selective protection of interstitial fibroblasts from apoptosis, leading to a prolonged life-span of fibroblasts in Ksp-b-cat-/-kidneys. Of note, although MMP-7 induces FasL expression in vitro, it alone does not significantly trigger fibroblast apoptosis in vivo, as illustrated by Bax expression and TUNEL staining (Figure 7) . Nevertheless, it potentiates staurosporine-induced fibroblast death. As staurosporine triggers cell apoptosis via an intrinsic, mitochondria-dependent pathway 43, 44 , these results suggest that fibroblast depletion in vivo probably requires a synergy between extrinsic and intrinsic apoptosis pathways.
The present study also shows that tubular depletion of b-catenin does not significantly affect tubular cell apoptosis after UUO ( Figure 5 ). This finding is not in line with early reports suggesting that b-catenin plays a role in promoting tubular cell survival after acute kidney injury (AKI) 31, 32 . Such a discrepancy could be related to the distinct nature of the injuries in AKI versus CKD. Therefore, the impact of b-catenin on renal cell survival/apoptosis varies depending on the type of cells being studied as well as the nature of injury being induced. Along this line, it should also be pointed out that despite the insignificant impact on fibrosis after genetic ablation of tubular bcatenin (Figures 1 and 2) , numerous studies indubitably demonstrate that blockade of Wnt/b-catenin via different approaches is effective in preventing fibrotic lesions after kidney injury 19, [23] [24] [25] . As the upregulation of Wnt/b-catenin is a common finding in virtually all kinds of CKD 20, 21 , whether the result of genetic knockout of bcatenin prior to injury is relevant to clinical setting is uncertain. Furthermore, we also cannot exclude the possibility that these results could be due to the specific model used and might not be applicable to other models of fibrosis. Due to these limitations, one should exercise cautions when interpret the data. Nonetheless, our studies unravel a novel mechanism by which tubular b-catenin signaling controls the fate of interstitial fibroblasts via MMP-7/FasL pathway. This study also illustrates that fibroblast apoptosis/depletion, in addition to its generation, is another major determinant of the net mass of the fibroblast population and the severity of renal fibrosis in diseased kidneys.
Methods
Animal model. Generation and genotyping of conditional knockout mice (Ksp-b-cat-/-) with tubule-specific ablation of b-catenin was described previously ) within the same litters. All animals were born at the expected Mendelian frequency; and they were normal in size and did not display any gross physical or behavioral abnormalities. Age-and sex-matched Ksp-b-cat-/-and control mice were used. Unilateral ureteral obstruction (UUO) was performed as described previously 38 . At 3 or 7 days after surgery, groups of mice were euthanized, and kidney tissues collected for subsequent analyses. Animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Pittsburgh.
Histology and immunohistochemical staining. Paraffin-embedded mouse kidney sections (3-mm thickness) were prepared by a routine procedure. The sections were stained with hematoxylin-eosin (HE), periodic acid-Schiff (PAS) and Masson's Trichrome staining reagents by standard protocol, respectively. Immunohistochemical staining was performed according to the established protocol as described previously 23 . The antibodies against b-catenin (ab15180; Abcam, Cambridge, MA), a-SMA (Ab5694-100; Abcam), E-cadherin (#3195; Cell Signaling Technology, Danvers, MA), vimentin (#5741s; Cell Signaling Technology), PCNA (sc-56), Bax (sc-493; Santa Cruz Biotechnology, Santa Cruz, CA) and MMP-7 (#104658; GeneTex Inc., Irvine, CA) were used.
Immunofluorescence staining and confocal microscopy. Kidney cryosections were fixed with 3.7% paraformaldehyde for 15 min at room temperature and immersed in 0.2% Triton X-100 for 10 min. After blocking with 10% donkey serum in PBS for 1 h, slides were immunostained with following antibodies: anti-fibronectin (F3648; Detection of apoptotic cells. Apoptotic cell death was determined by using terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining with DeadEnd Colorimetric or Fluorometric Apoptosis Detection System (Promega, Madison, WI), as described previously 31 .
Real-time RT-PCR. Total RNA isolation and real-time RT-PCR were carried out by the procedures described previously 38 . Briefly, first strand cDNA synthesis was carried out by using a reverse transcription system kit according to the instructions of the manufacturer (Promega). Quantitative, real-time RT-PCR (qRT-PCR) was performed on an ABI PRISM 7000 sequence detection system (Applied Biosystems, Foster City, CA) as described previously. The sequences of the primer pairs for mouse fibronectin, collagen III and a-SMA were reported previously 25 . The primer pairs for TGF-b1, CTGF and MMP7 were as follows: mouse TGF-b1, 59-GTGGAAATCAA-CGGGATCAG-39 (sense) and 59-GTTGGTATCCAGGGCTCTCC-39 (anti-sense); mouse CTGF, 59-CCTGGTCCAGACCACAGAGT-39 (sense) and 59-TTTTCCT-CCAGGTCAGCTTC-39 (anti-sense); mouse MMP-7, 59-TAGGCGGAGATGCT-CACTTT -39 (sense) and 59-TTCTGAATGCCTGCAATGTC -39 (anti-sense). PCR was run by using standard conditions. The mRNA levels of various genes were calculated after normalizing with b-actin.
Western blot analysis. Kidney tissues were lysed with radioimmunoprecipitation assay (RIPA) buffer containing 1% NP-40, 0.1% SDS, 100 mg/ml PMSF, 1% protease inhibitor cocktail, and 1% phosphatase I and II inhibitor cocktail (Sigma) in PBS on ice. The supernatants were collected after centrifugation at 13,000 3 g at 4uC for 15 min. Protein expression was analyzed by Western blot analysis as described previously 25 . The primary antibodies used were as follows: anti-b-catenin (#610154; BD Transduction Laboratories, San Jose, CA), anti-fibronectin (F3648; Sigma), antia-SMA (A2547; Sigma), anti-PAI-1 (sc-5297), anti-E-cadherin (#3195; Cell Signaling Technology, Danvers, MA), anti-vimentin (V2258; Sigma, St. Louis, MO), anti-Bax (sc-493), anti-FasL (sc-6237), anti-PCNA (sc-56), anti-c-Myc (sc-40s) and anti-actin (sc-1616) (Santa Cruz Biotechnology), anti-a-tubulin (T9026; Sigma) and anti-GAPDH (AM4300; Ambion, Austin, TX).
Cell culture and transfection. Normal rat kidney interstitial fibroblast (NRK-49F) cells were obtained from ATCC (Manassas, VA). Cells were maintained as described previously 25 . Serum-starved NRK-49F cells were treated with recombinant MMP-7 (#444270; EMD Chemicals, Gibbstown, NJ) for various periods of time at the concentrations as indicated. For some experiments, NRK-49F cells were also treated with 0.1 mM staurosporine (S4400; Sigma) and MMP-7 for various periods of time as indicated, and then subjected to TUNEL staining and Western blot analyses, respectively. 
